SCHEMBL30764071

SCHEMBL30764071

Cc1ccccc1NC(=O)/C=C/C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 4/20 0.71
▸ MMP2 P08253 4/20 0.71
▸ MMP9 P14780 4/20 0.71
▸ EGFR P00533 1/20 0.71
▸ KDM4E B2RXH2 3/20 0.69
▸ MAPT P10636 2/20 0.69
▸ PKM P14618 1/20 0.69
▸ ALDH1A1 P00352 7/20 0.65
▸ SMN1; SMN2 Q16637 3/20 0.64
▸ LMNA P02545 2/20 0.64
▸ HPGD P15428 4/20 0.63
▸ CYP2C9 P11712 2/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ KMT2A Q03164 1/20 0.63
▸ HTT P42858 2/20 0.62
▸ LPAR2 Q9HBW0 1/20 0.62
▸ LPAR3 Q9UBY5 1/20 0.62
▸ NPC1 O15118 2/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ RECQL P46063 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5177399 1.00 MMP1 (0.71) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL9360564 1.00 MMP1 (0.71) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL5176479 1.00 MMP1 (0.71) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL11140030 0.87 KDM4E (0.81) KDM4EMAPTPKMALDH1A1SMN1; SMN2
SCHEMBL11140025 0.87 KDM4E (0.81) KDM4EMAPTPKMALDH1A1SMN1; SMN2
SCHEMBL7826073 0.86 ALDH1A1 (0.65) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL7826069 0.86 ALDH1A1 (0.65) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL28884330 0.84 ALDH1A1 (0.65) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL23306418 0.84 MMP1 (0.68) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL7622295 0.84 MMP1 (0.68) MMP1MMP2MMP9EGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912831-B2 Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers ISP INVESTMENTS LLC (US) 2024-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912831-B2 Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers MMAB, PCNA, HMBS MMP1 1162/4885MMP2 962/4885MMP9 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback